Article
CA repeat polymorphism in the insulin-like growth factor-I gene is associated with increased risk of prostate cancer and benign prostatic hyperplasia.
International journal of oncology - 1 Jan 2005
Tsuchiya Norihiko, Wang Lizhong, Horikawa Yohei, Inoue Takamitsu, Kakinuma Hideaki, Matsuura Shinobu, Sato Kazunari, Ogawa Osamu, Kato Tetsuro, Habuchi Tomonori
Abstract excerpt
Insulin-like growth factor-I (IGF-I) plays an important role in prostate growth, hyperplasia, and carcinogenesis. Circulating IGF-I levels may be modulated by a genetic cytosine-adenine (CA) repeat polymorphism in the promoter region of IGF-I. The association of the polymorphism with the risk of prostate cancer and benign prostatic hyperplasia (BPH) was explored in 303 patients with prostate cancer, 219 patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
